Top News

Merck and Moderna logos displayed on a white background

RESEARCH

16 Jan 2026

mRNA Developers Regroup After Trial Setbacks

After late-stage failures, mRNA leaders narrow pipelines, double down on vaccines and cancer, and adopt tougher capital discipline

mRNA vaccine vial on medical documents with pills, syringe, and stethoscope

MARKET TRENDS

5 Feb 2026

mRNA Deals Push the Industry Beyond Vaccines

Biotech executives mark a major corporate milestone during a Nasdaq ceremony

PARTNERSHIPS

20 Jan 2026

GSK’s $2.2B Bet Signals a New Phase in Allergy Drug Races

Latest News

PARTNERSHIPS
31 Mar 2026
RNA Meets Cell Therapy, and Texas Is Holding the Handshake
REGULATORY
26 Mar 2026
No Trial? No Problem. FDA Rewrites the RNA Rules
INVESTMENT
23 Mar 2026
New Funding Backs Precision in mRNA Medicine
PARTNERSHIPS
17 Mar 2026
Fatty Bubbles and the $2.25 Billion Peace

Moderna's Flu Vaccine Clears a Regulatory Hurdle

Syringe being filled with vaccine dose in laboratory setting

REGULATORY

12 Mar 2026

A swift FDA reversal puts Moderna's mRNA flu shot back on track and sharpens the regulatory playbook for RNA developers

3D illustration of mRNA strands representing emerging in-vivo cancer cell therapy technology

INNOVATION

2 Jun 2025

mRNA Rewrites the Rules of Cancer Cell Therapy

Myeloid's in-body mRNA tech aims to make cancer treatment faster, cheaper, and more widely available.

9 10

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.